Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Presigen IV
- Development stage
- Preclinical
- Lead developer
- Medicinal Technologies
- Modality
- Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Classical Binding Small Molecules → Small Molecules
- Administration
- Oral
01
Overview
Presigen IV is a novel biocellular stimulation formula developed by Medicinal Technologies under the guidance of Dr. Sheryene Tejeda. It is designed to regulate intraocular pressure (IOP) and manage glaucoma, photophobia, and ocular hypertension. The formulation is based on an applied Biocellular-Sensory Matrix (BSM-IV) and incorporates ocular-supporting nutrients and botanical extracts, including allicin (from *Allium sativum*), *Momordica charantia*, *Syzygium aromaticum*, Vitamin C, Vitamin E, and zinc. Presigen IV works through multiple mechanisms, including enhancing aqueous humor drainage via the trabecular meshwork and Schlemm's canal, reducing chronic ocular inflammation, combating oxidative stress, and providing neuroprotective support to retinal ganglion cells.
- Brand names
- PresigenPresigen IV
- Other names
- Biocellular-Sensory Matrix 4Biocellular-Sensory Matrix IVBSM-IVBSM4BSM-4BSM 4
Beyond the preview
Go deeper on Presigen IV.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Presigen IV.